M Voegeli

Michèle Voegeli 2 collaborations

A A Moccia 1 collaboration

S Aeppli 1 collaboration

S Güsewell 1 collaboration

M Bargetzi 1 collaboration

C Caspar 1 collaboration

D Brülisauer 1 collaboration

M Ebnöther 1 collaboration

M Fehr 1 collaboration

N Fischer 1 collaboration

G Ghilardi 1 collaboration

F Krasniqi 1 collaboration

N Lang 1 collaboration

U Mey 1 collaboration

W Mingrone 1 collaboration

U Novak 1 collaboration

C Pfleger 1 collaboration

P Richter 1 collaboration

M Rütti 1 collaboration

A Schmidt 1 collaboration

F Stenner 1 collaboration

T Zander 1 collaboration

E Zucca 1 collaboration

F Hitz 1 collaboration

Urban Novak 1 collaboration

Martin Fehr 1 collaboration

Sämi Schär 1 collaboration

Martin Dreyling 1 collaboration

Christian Schmidt 1 collaboration

Enrico Derenzini 1 collaboration

Thilo Zander 1 collaboration

Georg Hess 1 collaboration

Ulrich Mey 1 collaboration

Simone Ferrero 1 collaboration

Nicolas Mach 1 collaboration

Carola Boccomini 1 collaboration

Sebastian Böttcher 1 collaboration

Anne Cairoli 1 collaboration

Vanesa-Sindi Ivanova 1 collaboration

Thomas Menter 1 collaboration

Stefan Dirnhofer 1 collaboration

Bernhard Scheibe 1 collaboration

Sandra Gadient 1 collaboration

Katrin Eckhardt 1 collaboration

Emanuele Zucca 1 collaboration

Christoph Driessen 1 collaboration

Christoph Renner 1 collaboration

Meret Petitat-Berli 1 collaboration

Marie Knufinke 1 collaboration

Martina Sonderegger 1 collaboration

Bettina Seifert 1 collaboration

Elena Diana Chiru 1 collaboration

Pirmin Haeuptle 1 collaboration

Lisanne Van't Walderveen 1 collaboration

Robert Rosenberg 1 collaboration

Emanuel Burri 1 collaboration

Svetozar Subotic 1 collaboration

Fabienne Dominique Schwab 1 collaboration

Vérène Dougoud-Chauvin 1 collaboration

Heinz Unger 1 collaboration

Kirsten Mertz 1 collaboration

Loay Tahan 1 collaboration

Marcus Vetter 1 collaboration

Affiliations

Publications (3)

Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland.

Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13).

Precision Oncology in Older Cancer Patients: A Single-Center Experience.

Réseau de co-auteurs